← Leaderboards
Dennis J Slamon
University Of California Los Angeles
$8,011,664
Attributed
$8,011,664
Total exposure
11
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.1M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,892,550 · 12
By mechanism
P01$9,243,860 · 4
P30$5,596,543 · 4
T32$1,513,935 · 1
M01$414,532 · 1
U54$114,680 · 1
R13$9,000 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Tzung K Hsiai$18,151,559
- Joshua Grill$12,357,372
- Bruce H Dobkin$8,381,630
- Michael A Poles$2,163,426
- Michael L Prendergast$14,988,548
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchMalignant NeoplasmsClinical TrialsResearch PersonnelPrincipal InvestigatorOvary NeoplasmsReportingCommunitiesAuthorityMonitorFacultySafetyCancer Center Support GrantFundingTrainingComprehensive Cancer CenterDoctor Of PhilosophyEnrollmentProtocol DevelopmentMinorityMemberOncologyBreast NeoplasmsPrograms
Grant awards (36)
Clinical Protocol and Data Management (CPDM)$622,558
P30 · FY2025 · CA · contact PI
Clinical Protocol and Data Management$382,602
P30 · FY2024 · CA · contact PI
Clinical Protocol and Data Management$382,607
P30 · FY2023 · CA · contact PI
Clinical Protocol and Data Management$382,607
P30 · FY2022 · CA · contact PI
Clinical Protocol and Data Management$382,607
P30 · FY2021 · CA · contact PI
Clinical Protocol and Data Management$441,633
P30 · FY2020 · CA · contact PI
CRU - Clinical Research Unit Shared Resource$323,342
P30 · FY2013 · CA · contact PI
CRU - Clinical Research Unit Shared Resource$445,117
P30 · FY2012 · CA · contact PI
CRU - Clinical Research Unit Shared Resource$654,847
P30 · FY2011 · CA · contact PI
The Transcription Factor SLUG may Drive the Progression of Akt and HER2/neu$37,703
U54 · FY2011 · CA · contact PI
CRU - Clinical Research Unit Shared Resource$810,771
P30 · FY2010 · CA · contact PI
The Transcription Factor SLUG may Drive the Progression of Akt and HER2/neu$38,869
U54 · FY2010 · CA · contact PI
CRU - Clinical Research Unit Shared Resource$767,852
P30 · FY2009 · CA · contact PI
The Transcription Factor SLUG may Drive the Progression of Akt and HER2/neu$38,108
U54 · FY2009 · CA · contact PI
Signal Transduction in Oncogenesis$1,555,483
P01 · FY2006 · CA · contact PI
Signal Transduction in Oncogenesis$1,552,302
P01 · FY2005 · CA
Academic Training in Medical Oncology$286,323
T32 · FY2005 · CA
Signal Transduction in Oncogenesis$281,091
P01 · FY2005 · CA
Signal Transduction in Oncogenesis$1,512,817
P01 · FY2004 · CA
Academic Training in Medical Oncology$277,252
T32 · FY2004 · CA
Signal Transduction in Oncogenesis$273,349
P01 · FY2004 · CA
Signal Transduction in Oncogenesis$1,661,328
P01 · FY2003 · CA
Academic Training in Medical Oncology$276,177
T32 · FY2003 · CA
Signal Transduction in Oncogenesis$265,832
P01 · FY2003 · CA
Signal Transduction in Oncogenesis$1,431,411
P01 · FY2002 · CA
Signal Transduction in Oncogenesis$258,533
P01 · FY2002 · CA
Academic Training in Medical Oncology$246,662
T32 · FY2002 · CA
HER-2/NEU ALTERATIONS IN BREAST AND OVARIAN CANCER$181,487
P01 · FY2002 · CA
CORE--TISSUE BANK$0
P01 · FY2002 · CA
Academic Training in Medical Oncology$246,498
T32 · FY2001 · CA
PHASE I STUDY IN PATIENTS WITH PERITONEAL CARCINOMATOSIS USING SCH58500$207,266
M01 · FY2001 · RR
PHASE I STUDY IN PATIENTS WITH PERITONEAL CARCINOMATOSIS USING SCH58500$207,266
M01 · FY2001 · RR
HER-2/NEU ALTERATIONS IN BREAST AND OVARIAN CANCER$181,487
P01 · FY2000 · CA
ACADEMIC TRAINING IN MEDICAL ONCOLOGY$181,023
T32 · FY2000 · CA
SIGNAL TRANSDUCTION IN ONCOGENESIS$88,740
P01 · FY2000 · CA
ADVANCES IN HUMAN BREAST AND PROSTATE CANCER$9,000
R13 · FY2000 · CA